Common Stock, Shares, Outstanding of Checkpoint Therapeutics, Inc. from 31 Dec 2015 to 31 Mar 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Checkpoint Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2015 to 31 Mar 2025.
  • Checkpoint Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Mar 2025 was 83,063,733, a 137% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Checkpoint Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 83,063,733 +48,077,454 +137% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 53,640,422 +26,598,387 +98% 31 Dec 2024 10-Q 13 May 2025 2025 Q1
Q3 2024 45,095,500 +23,392,953 +108% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 41,631,500 +24,393,107 +142% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 34,986,279 +21,785,209 +165% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 27,042,035 +17,455,352 +182% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 21,702,547 -64,141,773 -75% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 17,238,393 -67,667,358 -80% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 13,201,070 -70,600,172 -84% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 9,586,683 +1,829,243 +24% 31 Dec 2022 10-K 22 Mar 2024 2023 FY
Q3 2022 85,844,320 +9,629,922 +13% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 84,905,751 +9,163,878 +12% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 83,801,242 +11,637,420 +16% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 7,757,440 -54,662,999 -88% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 76,214,398 +15,331,095 +25% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 75,741,873 +24,761,869 +49% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 72,163,822 +24,125,316 +50% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 62,420,439 +15,415,675 +33% 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q3 2020 60,883,303 +29,717,270 +95% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 50,980,004 +21,019,970 +70% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 48,038,506 +19,156,750 +66% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 47,004,764 +19,928,610 +74% 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q3 2019 31,166,033 +4,169,795 +15% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 29,960,034 +4,852,170 +19% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 28,881,756 +3,866,668 +15% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 27,076,154 +8,563,725 +46% 31 Dec 2018 10-K 11 Mar 2020 2019 FY
Q3 2018 26,996,238 +8,627,663 +47% 30 Sep 2018 10-Q 02 Nov 2018 2018 Q3
Q2 2018 25,107,864 +6,849,289 +38% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 25,015,088 +6,796,513 +37% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 18,512,429 +1,085,553 +6.2% 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q3 2017 18,368,575 +1,322,699 +7.8% 30 Sep 2017 10-Q 03 Nov 2017 2017 Q3
Q2 2017 18,258,575 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 18,218,575 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 17,426,876 +1,437,561 +9% 31 Dec 2016 10-K 16 Mar 2018 2017 FY
Q3 2016 17,045,876 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q4 2015 15,989,315 31 Dec 2015 10-K 21 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.